Novo’s Blockbuster Obesity Drug Still Hit by US Bottlenecks
Novo Nordisk A/S said the supply of its blockbuster obesity medicine Wegovy will continue to be restricted in
1970-01-01 08:00
Tainted Medication Fears Spur US Defense Department to Seek Outside Testing
The US Department of Defense entered an agreement with Valisure, an independent lab that’s spotted dangerous chemicals in
1970-01-01 08:00
A $2.8 Million Miracle Therapy Eludes Some Long-Suffering Patients
Liany Benedi long dreamed of a cure for the disease that has shadowed her since she was 2
1970-01-01 08:00
Weight-Loss Stocks Soar After Obesity-Drug Study Spurs Investor Frenzy
Wall Street’s enthusiasm for all things weight-loss related got a fresh boost Tuesday after results for a Novo
1970-01-01 08:00
Bayer’s New CEO Says Nothing Off Table in Strategic Review
Bayer AG Chief Executive Officer Bill Anderson said nothing is off the table as he reviews the company’s
1970-01-01 08:00
Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows
Novo Nordisk A/S shares surged to a record after the Danish company’s blockbuster obesity medicine Wegovy reduced the
1970-01-01 08:00
Bayer Lowers Revenue Forecasts for Crops and Drugs Units
Bayer AG reduced its sales forecasts for its crop science and pharma divisions this year, accounting for the
1970-01-01 08:00
Elon Musk's Neuralink Raises $280 Million to Develop Brain Implants
Neuralink Corp., Elon Musk’s brain-implant company, has raised $280 million in new funding from investors to develop its
1970-01-01 08:00
Biotech Firm Vistagen Surges 1,370% on Social Anxiety Spray Trial Success
A beaten down micro-cap biotech company, Vistagen Therapeutics Inc., is having its best day ever, surging north of
1970-01-01 08:00
Tinseltown Troubles Torment Studios: Earnings Week Ahead
This week’s entertainment industry earnings are all about the labor disputes gripping Hollywood, as twin strikes by the
1970-01-01 08:00
Sage Tumbles as Depression Pill Approval Omits Major Disorder
Sage Therapeutics Inc. slumped in early trading after regulators granted approval to its fast-acting pill only for postpartum
1970-01-01 08:00
Rakuten’s Mikitani Spends a Fifth of His Time on Biotech Startup
Hiroshi Mikitani, whose Rakuten Group Inc. is losing billions of dollars to break into Japan’s wireless market, said
1970-01-01 08:00